Phase 1 Nears Completion
Research I 25 May 2023 EuroACT Phase 1 nears completion Where are we at? The end of Phase 1 Task 1 has resulted in 1262 Patient Related Outcomes (PROs) identified in the targeted literature review across all disease areas. The list of PROs is currently being reviewed by patient organisations in each
WECAN statement concerning ECPC
Statement I 27 Feb 2023 I Updated 03 March 2023 WECAN statement concerning recent reports about the European Cancer Patient Coalition (ECPC) and the potential impact on EU research projects For the past two decades, the European cancer patient community has worked hard to become competent, reliable, and trusted partners of researchers and
Survey on Legal Agreements
Projects I 24 Feb 2023 A WECAN update: Reasonable Agreements between Patient Organisations and Pharmaceutical Companies (RAPP), aka the Legal Agreements project Since 2016, our community has been talking with pharma about issues faced when negotiating legal agreements around patient engagement. In the implementation phase of this important project, we are continuing that
Phase 1 Task 1 Completed
Research I 08 Feb 2023 EuroACT Phase 1 meets halfway point The second steering committee meeting concerning the first task within Phase 1, was held on the 1st of February. The aim of task 1 was to identify the most relevant peer-reviewed articles on PROM use practices in the field of oncology
2022 Activity Report- A Year in Review
WECAN 2022 Activity Report A Year in Review 2022 has been an eventful and turbulent year for European cancer patients. More than two years of the pandemic left its traces on cancer treatment, care, mental health and cancer research. The Ukraine war created an unprecedented humanitarian crisis and many cancer patients needed urgent